TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,872 Cr | ₹2,673 Cr | ₹2,352 Cr | ₹1,847 Cr | ₹1,226 Cr |
What is the latest Profit Before Tax of TORRENT PHARMACEUTICALS ?
| Year | Profit Before Tax |
|---|---|
| Mar2026 | ₹2,872 Cr |
| Mar2025 | ₹2,673 Cr |
| Mar2024 | ₹2,352 Cr |
| Mar2023 | ₹1,847 Cr |
| Mar2022 | ₹1,226 Cr |
How is Profit Before Tax of TORRENT PHARMACEUTICALS Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,872 Cr | 7.46 | |
| Mar2025 | ₹2,673 Cr | 13.63 | |
| Mar2024 | ₹2,352 Cr | 27.34 | |
| Mar2023 | ₹1,847 Cr | 50.68 | |
| Mar2022 | ₹1,226 Cr | - | |
Compare Profit Before Tax of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹161,301.7 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| MANKIND PHARMA | ₹102,896.0 Cr | -0.7% | 5.4% | 0.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -3.7% |
7.2% |
49.8% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses